In the post-crisis world, an increasing number of banks have set up a centralized XVA desk. With the introduction of new regulations to ensure banks are adequately capitalized, it has become common practice to include certain costs in the pricing of OTC derivatives that, in many cases, had previously been ignored. To assist in the pricing for the cost of dealing with a counterparty in a derivative transaction, the markets have developed various metrics including CVA, DVA, FVA, ColVA, KVA, and MVA— collectively known as XVAs.
One of the key challenges of XVAs is that adjustments need to be calculated on a portfolio basis rather than trade-by-trade. This requires dealing with a large number of computations and orders of magnitude more calculations for accurate results. The calculation of XVAs is highly complex, combining the intricacies of derivative pricing with the computational challenges of simulating a full universe of risk factors. Given the strategic importance of XVA, banks require enhanced capabilities and modern infrastructures to calculate the required credit, funding, and capital adjustments. As banks look to reduce, mitigate, and optimize XVA and other capital charges, they are making an investment in XVA capabilities in an attempt to solve the computational challenge of simulating a full universe of risk factors.
Another key challenge is how to efficiently calculate XVA sensitivities. While sensitivities have always been an important component of XVA desk risk management, the FRTB-CVA framework published by the Basel Committee in 2015 has made managing regulatory capital a priority for banks globally. This has further driven the demand for calculation of sensitivities. Banks that are unable to calculate CVA capital charge using the sensitivity-based FRTB approach will have to use the rather punitive formula-based basic approach.